Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Jake Dunning, Honorary Visiting Research Fellow in Tropical Medicine (ERGO) and Deputy Programme Director for High Consequence Infectious Diseases, NHS England, is appointed MBE for services to Clinical Research. Dr Dunning led clinical trials during the terrible Ebola epidemic in West Africa.

Jake Dunning wearing PPE and standing behind the fence in an Ebola healtcare facility hot zone
Dr Jake Dunning, Honorary Visiting Research Fellow at the Centre for Tropical Medicine and Global Health, has been awarded an MBE in the New Year's Honours list. The award recognises his services to clinical research, particularly his contributions to Ebola research efforts. Jake joined the Epidemic diseases Research Group Oxford (ERGO) in October 2014, as part of the RAPIDE trial team studying potential treatments for Ebola virus disease in West Africa. The trials, led by Prof Peter Horby, evaluated two candidate drugs at Ebola treatment centres in Liberia and Sierra Leone. Jake was the Field Lead for the trials, based in West Africa, and worked with over 40 researchers from 10 countries, including doctors and nurses from the affected countries.
Following completion of the trials in 2015, Jake moved to a new full time post as Consultant in Infectious Diseases at the National Infection Service, Public Health England. However, he continues to work with ERGO on preparedness and response activities for outbreak research. Additionally, Jake is the NHS England Deputy Programme Director for High Consequence Infectious Diseases, which includes diseases such as viral haemorrhagic fever, avian influenza, and pneumonic plague. He also practises clinical infectious diseases at the Royal Free Hospital, London. Along with other trial team members, Jake received a British Government Ebola Service Medal in 2015, and his international colleagues were recognised with the award of Oxford Ebola service medals.
On receiving his award, Jake said "I am very grateful to have received this honour, mindful that I was part of a brilliant and dedicated team. Without the extraordinary support of colleagues in the field and in Oxford, these unique and very challenging trials would not have happened. We are now applying the skills and lessons learned to improving outbreak preparedness, response and research activities for high consequence infections, both overseas and in the UK. I am indebted to Peter Horby and the Centre, for having provided me with such an amazing opportunity.

The full story is available on the University of Oxford website

Similar stories

Watch our webinar - Radical cure of vivax malaria: can we do better?

The three presentations and expert discussion by Dr Rob Commons, Dr Alison Roth and Dr James Watson, chaired by Professor Sir Nicholas White (Mahidol Oxford Research Unit) and Dr Chau Nguyen Hoang (Oxford University Clinical Research Unit), are now available.

Shobhana Nagraj, Women in Science

Clinical Researcher Shobhana Nagraj, from the Health Systems Collaboratives in Oxford, tells us about the female role models who inspired her to follow her dreams

Pilot study detects diverse DNA in ingredients of falsified tablets

A recent multidisciplinary pilot study, originating from LOMWRU and the Medicine Quality Research Group of IDDO and MORU, investigated whether bacterial, plant, fungal and animal DNA in the ingredients and from the environment (eDNA) could be detected from falsified (aka counterfeit) tablets.

Expert Comment: Biotechnology allows us to make unprecedented interventions for conservation

In the wake of high-profile reports on the devastating toll human activity has had on global biodiversity, nations are expected to adopt the Convention on Biodiversity post-2020 framework that outlines measures to ensure humans live in harmony with nature.

Researchers call for antimicrobial resistance surveillance to be improved

The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.

Meta-analysis informed the updated WHO guidelines for treatment of uncomplicated malaria in the first trimester of pregnancy

A new WWARN meta-analysis, commissioned by the World Health Organization and which informed a change to its treatment guidelines, has been published in The Lancet. The study provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first trimester.